Literature DB >> 20705938

Human influenza is more effective than avian influenza at antiviral suppression in airway cells.

Alan Chen-Yu Hsu1, Ian Barr, Philip M Hansbro, Peter A Wark.   

Abstract

Airway epithelial cells are the initial site of infection with influenza viruses. The innate immune responses of airway epithelial cells to infection are important in limiting virus replication and spread. However, relatively little is known about the importance of this innate antiviral response to infection. Avian influenza viruses are a potential source of future pandemics; therefore, it is critical to examine the effectiveness of the host antiviral system to different influenza viruses. We used a human influenza (H3N2) and a low-pathogenic avian influenza (H11N9) to assess and compare the antiviral responses of Calu-3 cells. After infection, H3N2 replicated more effectively than the H11N9 in Calu-3 cells. This was not due to differential expression of sialic acid residues on Calu-3 cells, but was attributed to the interference of host antiviral responses by H3N2. H3N2 induced a delayed antiviral signaling and impaired type I and type III IFN induction compared with the H11N9. The gene encoding for nonstructural (NS) 1 protein was transfected into the bronchial epithelial cells (BECs), and the H3N2 NS1 induced a greater inhibition of antiviral responses compared with the H11N9 NS1. Although the low-pathogenic avian influenza virus was capable of infecting BECs, the human influenza virus replicated more effectively than avian influenza virus in BECs, and this was due to a differential ability of the two NS1 proteins to inhibit antiviral responses. This suggests that the subversion of human antiviral responses may be an important requirement for influenza viruses to adapt to the human host and cause disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705938      PMCID: PMC3135850          DOI: 10.1165/rcmb.2010-0157OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  45 in total

Review 1.  A weak signal for strong responses: interferon-alpha/beta revisited.

Authors:  T Taniguchi; A Takaoka
Journal:  Nat Rev Mol Cell Biol       Date:  2001-05       Impact factor: 94.444

2.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

3.  Viral infections activate types I and III interferon genes through a common mechanism.

Authors:  Kazuhide Onoguchi; Mitsutoshi Yoneyama; Azumi Takemura; Shizuo Akira; Tadatsugu Taniguchi; Hideo Namiki; Takashi Fujita
Journal:  J Biol Chem       Date:  2007-01-04       Impact factor: 5.157

4.  Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.

Authors:  Shoudong Li; Ji-Young Min; Robert M Krug; Ganes C Sen
Journal:  Virology       Date:  2006-02-08       Impact factor: 3.616

5.  Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  1991-11       Impact factor: 10.793

6.  Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery.

Authors:  Z Chen; Y Li; R M Krug
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

7.  RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.

Authors:  Andreas Pichlmair; Oliver Schulz; Choon Ping Tan; Tanja I Näslund; Peter Liljeström; Friedemann Weber; Caetano Reis e Sousa
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

8.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.

Authors:  Taro Kawai; Ken Takahashi; Shintaro Sato; Cevayir Coban; Himanshu Kumar; Hiroki Kato; Ken J Ishii; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2005-08-28       Impact factor: 25.606

9.  Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7.

Authors:  I Marié; J E Durbin; D E Levy
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

10.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses.

Authors:  Sang Heui Seo; Erich Hoffmann; Robert G Webster
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

View more
  19 in total

1.  Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases.

Authors:  Gang Liu; Marion A Cooley; Andrew G Jarnicki; Alan C-Y Hsu; Prema M Nair; Tatt Jhong Haw; Michael Fricker; Shaan L Gellatly; Richard Y Kim; Mark D Inman; Gavin Tjin; Peter A B Wark; Marjorie M Walker; Jay C Horvat; Brian G Oliver; W Scott Argraves; Darryl A Knight; Janette K Burgess; Philip M Hansbro
Journal:  JCI Insight       Date:  2016-06-16

2.  MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD.

Authors:  Alan C-Y Hsu; Kamal Dua; Malcolm R Starkey; Tatt-Jhong Haw; Prema M Nair; Kristy Nichol; Nathan Zammit; Shane T Grey; Katherine J Baines; Paul S Foster; Philip M Hansbro; Peter A Wark
Journal:  JCI Insight       Date:  2017-04-06

3.  Effects of receptor binding specificity of avian influenza virus on the human innate immune response.

Authors:  Irene Ramos; Dabeiba Bernal-Rubio; Natasha Durham; Alan Belicha-Villanueva; Anice C Lowen; John Steel; Ana Fernandez-Sesma
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

4.  A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis.

Authors:  Emma L Beckett; Richard L Stevens; Andrew G Jarnicki; Richard Y Kim; Irwan Hanish; Nicole G Hansbro; Andrew Deane; Simon Keely; Jay C Horvat; Ming Yang; Brian G Oliver; Nico van Rooijen; Mark D Inman; Roberto Adachi; Roy J Soberman; Sahar Hamadi; Peter A Wark; Paul S Foster; Philip M Hansbro
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

5.  Response of primary human airway epithelial cells to influenza infection: a quantitative proteomic study.

Authors:  Andrea L Kroeker; Peyman Ezzati; Andrew J Halayko; Kevin M Coombs
Journal:  J Proteome Res       Date:  2012-07-02       Impact factor: 4.466

6.  Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection.

Authors:  Alan C-Y Hsu; Kristy Parsons; Ian Barr; Sue Lowther; Deborah Middleton; Philip M Hansbro; Peter A B Wark
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

7.  Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis.

Authors:  Steven B Smith; William Dampier; Aydin Tozeren; James R Brown; Michal Magid-Slav
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

8.  The placental protein syncytin-1 impairs antiviral responses and exaggerates inflammatory responses to influenza.

Authors:  Jorge M Tolosa; Kristy S Parsons; Philip M Hansbro; Roger Smith; Peter A B Wark
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

9.  Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD.

Authors:  Katherine J Baines; Alan C-Y Hsu; Melinda Tooze; Lakshitha P Gunawardhana; Peter G Gibson; Peter A B Wark
Journal:  Respir Res       Date:  2013-02-06

10.  Differential Induction of Type I and Type III Interferons by Swine and Human Origin H1N1 Influenza A Viruses in Porcine Airway Epithelial Cells.

Authors:  Venkatramana D Krishna; Erin Roach; Nathan A Zaidman; Angela Panoskaltsis-Mortari; Jessica H Rotschafer; Scott M O'Grady; Maxim C-J Cheeran
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.